These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9100752)

  • 41. Cytologic observations preceding high grade squamous intraepithelial lesions.
    Troncone G; Gupta PK
    Acta Cytol; 1995; 39(4):659-62. PubMed ID: 7631539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human papillomavirus typing and the reduction of cervical cancer risk.
    Jin XW; Cash J; Kennedy AW
    Cleve Clin J Med; 1999 Oct; 66(9):533-9. PubMed ID: 10535179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.
    Lörincz AT
    J Obstet Gynaecol Res; 1996 Dec; 22(6):629-36. PubMed ID: 9037955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients with various types of human papillomavirus: covariation and diagnostic relevance of cytological findings in Papanicolaou smears.
    Tanaka H; Chua KL; Lindh E; Hjerpe A
    Cytopathology; 1993; 4(5):273-83. PubMed ID: 8274665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Koilocytosis and squamous (pre)neoplasia as detected in population-based cervical screening: practice and theory.
    Boon ME; Boon LM; de Bosschere MJ; Verbruggen BS; Kok LP
    Eur J Gynaecol Oncol; 2005; 26(5):533-6. PubMed ID: 16285573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple HPV infection in cervical cancer screened by HPVDNAChip.
    Lee SA; Kang D; Seo SS; Jeong JK; Yoo KY; Jeon YT; Kim JW; Park NH; Kang SB; Lee HP; Song YS
    Cancer Lett; 2003 Aug; 198(2):187-92. PubMed ID: 12957357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of human papillomavirus in screening for cervical cancer.
    McFadden SE; Schumann L
    J Am Acad Nurse Pract; 2001 Mar; 13(3):116-25; quiz 127-8. PubMed ID: 11930583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of human papillomavirus detection rates by dot blot assay from smear and biopsy specimens with regard to human papillomavirus type and histologic diagnosis.
    Hukkanen VI; Auvinen E; Salmi T; Virtanen M; Kujari HP
    Am J Clin Pathol; 1994 Jun; 101(6):694-7. PubMed ID: 8209853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High prevalence rate of human papillomavirus infection and association with abnormal papanicolaou smears in sexually active adolescents.
    Rosenfeld WD; Vermund SH; Wentz SJ; Burk RD
    Am J Dis Child; 1989 Dec; 143(12):1443-7. PubMed ID: 2556023
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA hybridisation of cervical scrapes: comparison with cytological findings in Papanicolaou smears.
    Morse AR; Wickenden C; Byrne M; Taylor-Robinson D; Smith J; Anderson MC; Smith C; Malcolm AD; Coleman DV
    J Clin Pathol; 1988 Mar; 41(3):296-9. PubMed ID: 2834421
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human papillomavirus infection in atrophic smears. A case report.
    Luzzatto R; Poli M; Recktenvald M; Luzzatto L
    Acta Cytol; 2000; 44(3):420-2. PubMed ID: 10834003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporal associations of human papillomavirus infection with cervical cytologic abnormalities.
    Lorincz AT; Schiffman MH; Jaffurs WJ; Marlow J; Quinn AP; Temple GF
    Am J Obstet Gynecol; 1990 Mar; 162(3):645-51. PubMed ID: 2156423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What do you recommend for a patient with a Pap smear indicating atypical cells?
    Kennedy AW
    Cleve Clin J Med; 2000 Sep; 67(9):610-1. PubMed ID: 10992617
    [No Abstract]   [Full Text] [Related]  

  • 54. Diagnosis of human papillomatosis by polymerase chain reaction in cases of divergence between results of hybrid capture and papanicolaou cytology.
    Novaes LC; Novaes MR; Simões-Barbosa A
    Braz J Infect Dis; 2006 Jun; 10(3):169-72. PubMed ID: 17568847
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An evaluation of infectious diseases in cervicovaginal smears from patients with atypical cells of undetermined significance.
    Coach S; Cason Z; Benghuzzi H
    Biomed Sci Instrum; 2001; 37():167-72. PubMed ID: 11347382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of human papilloma virus infection in routine Papanicolaou-stained cervical smears.
    Chakrabarti RN; Bhattacharya D; Sarkhel T
    Eur J Gynaecol Oncol; 1987; 8(1):22-5. PubMed ID: 3032633
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The environmental cofactors in carcinogenesis in high risk HPV/HIV-positive women.
    Paulo M; Borges AB; Duarte G; Quintana SM; Montes MB; Toloi MR
    Braz J Infect Dis; 2007 Apr; 11(2):189-95. PubMed ID: 17625758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Telomerase-A molecular marker for cervical cancer screening.
    Reddy VG; Khanna N; Jain SK; Das BC; Singh N
    Int J Gynecol Cancer; 2001; 11(2):100-6. PubMed ID: 11328407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human papillomavirus reporting: minimizing patient and laboratory risk.
    Austin RM
    Arch Pathol Lab Med; 2003 Aug; 127(8):973-7. PubMed ID: 12873169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of smear specimens with biopsy specimens in a nucleic acid hybridization test for human papilloma virus (HPV) infection.
    Auvinen E; Hukkanen V; Lehmijoki J; Salmi T; Arstila P
    Acta Obstet Gynecol Scand; 1989; 68(7):627-31. PubMed ID: 2561043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.